SANDOZ POSACONAZOLE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 647fa182db17b411
Drug Approval Canada Name: SANDOZ POSACONAZOLE
Product Name: SANDOZ POSACONAZOLE
Status: Marketed
Status Date: 2020-12-08
Original Market Date: 2020-12-08
Din: 02496259
Drug Class: Human
Dosage Form: Tablet (Delayed-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:14.08
Atc Original: J02AC04 POSACONAZOLE
Atc Name: j 02 ac 04
Aig Number: 0152201002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

POSACONAZOLE

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

647fa182db17b411

Type

Standard